Bird Flu May Have Brought Stock Advancement for CureVac, +11%
Bird Flu May Have Brought Stock Advancement for CureVac, +11%
禽流感或许为curevac带来了股票增长，涨幅11%。
$CureVac (CVAC.US)$, a company testing trail vaccines for influenza, climbed 11% Thursday after in part the news of three cases of a new strain of bird flu in the U.S., called H5N1. Reuters also reported cases in Mexico.
$CureVac (CVAC.US)$一家针对流感测试疫苗的公司，在美国报告了三例新禽流感变异毒株H5N1感染病例的消息后，周四上涨了11％。路透社还报告了墨西哥的感染病例。
The firm dosed a patient with a phase 2 study on seasonal influenza as recently as last week, according to a press release.
据新闻稿披露，该公司最近一周在季节性流感的二期研究中给一个患者服药。